Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
HK.24.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GK.2.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.1.5.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HE.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JM.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HV.1.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.27NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.7.22NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GP.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.3.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBVNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.62NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GA.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.23NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2.3.13NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.110.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.23 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.9 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.74 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.621.1 (Mu)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.7.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.32NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.67NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CK.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BE.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.1.38NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.34NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.7.12NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CJ.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.21NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.4.6.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CM.7.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-15690.9US
BA.5.3.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.22NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
BF.7.19NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FA.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.464NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.234NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.231NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.243NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.517NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.291NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.258NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.349NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.314NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.132NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.38NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.7.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used